Report Published: "Zimbabwe Pharmaceuticals & Healthcare Report Q4 2014"
Zimbabwe's poor economic outlook, in addition to the government announcing budget cuts to healthcare, means that we do not expect any meaningful interest from pharmaceutical companies in the medium-to-long term. The already dire situation, in which the health service is heavily reliant on donations, lacks skilled workers and essential medicines, and the fact that the vast majority of the healthcare budget is not even disbursed, leads us to hold a very bleak outlook for the healthcare market in the country.
View full press release